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Comparison of genome sequences from clinical isolates of Mycobacterium tuberculosis
with phylogenetically-related pathogens Mycobacterium marinum, Mycobacterium
kansasii, and Mycobacterium leprae reveals diversity amongst genes associated
with vitamin B12-related metabolism. Diversity is generated by gene deletion
events, differential acquisition of genes by horizontal transfer, and single nucleotide
polymorphisms (SNPs) with predicted impact on protein function and transcriptional
regulation. Differences in the B12 synthesis pathway, methionine biosynthesis, fatty acid
catabolism, and DNA repair and replication are consistent with adaptations to different
environmental niches and pathogenic lifestyles. While there is no evidence of further gene
acquisition during expansion of the M. tuberculosis complex, the emergence of other
forms of genetic diversity provides insights into continuing host-pathogen co-evolution
and has the potential to identify novel targets for disease intervention.
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Strains belonging to the Mycobacterium tuberculosis complex
evolved by clonal expansion from a common ancestral popula-
tion shared with Mycobacterium canettii, an occasional human
pathogen closely resembling M. tuberculosis in terms of disease
and evolution. M. tuberculosis and M. canettii share close phylo-
genetic links to other pathogens including Mycobacterium leprae,
Mycobacterium marinum [and the derived Mycobacterium ulcer-
ans (Doig et al., 2012)], and Mycobacterium kansasii (Figure 1)
(Cole et al., 1998; Stinear et al., 2008; Supply et al., 2013; Blouin
et al., 2014). There was an early division of the M. tubercu-
losis complex into two major branches (Brosch et al., 2002).
The branch characterized by a 2 kb RD9 deletion and a sin-
gle nucleotide polymorphism (SNP) that inactivates pyruvate
kinase (Keating et al., 2005) gave rise to two lineages associ-
ated with human tuberculosis in West Africa (referred to as
M. africanum) and a series of animal-adapted variants includ-
ing M. bovis, M. orygis, M. microti, and M. pinnipedii (Comas
et al., 2013). The branch with an intact pyruvate kinase diver-
sified into five human lineages with patterns of geographic
distribution and phylogenetic coalescence consistent with their
having co-evolved with populations of modern humans migrat-
ing out of Africa around the Indian Ocean and across Eurasia
(Comas et al., 2013). While the animal strains often retain the
ability to cause sporadic cases of human disease (Bos et al.,
2014), they do not generally establish an effective transmis-
sion cycle. Similarly, while human strains of M. tuberculosis
can be isolated from cattle lesions in low prevalence herds
(Berg et al., 2009), a high prevalence of bovine tuberculo-
sis is always associated with cattle-adapted M. bovis (Firdessa
et al., 2012). Epidemiological evidence suggests that individual
human lineages are optimized for transmission within particular
ethnic groups, providing a further indication of co-evolution
between host and pathogen (Gagneux et al., 2006; Fenner et al.,
2013).
Despite sustained efforts to deliver optimal therapy over the
last two decades, tuberculosis remains a major global health prob-
lem. Treatment of clinical disease undoubtedly saves lives and
reduces suffering, but there are limitations to its effectiveness
as a strategy to block transmission and there is a need for vac-
cines and preventive therapies that will arrest the disease process
prior to development of an infectious state (Dye et al., 2013).
Identification of molecular determinants that influence the trans-
mission efficiency of the different host-adapted genotypes may
point the way to novel interventions targeted toward disease con-
trol at a population level. It is anticipated that genetic changes
that have a functional impact on pathogenesis will influence the
repertoire of molecules that interact with the host immune system
and the metabolic networks that support growth and survival in
particular environmental niches. In this review we investigate the
potential of combining phylogenetic andmetabolic approaches to
dissect events in the evolution of M. tuberculosis.
BIOSYNTHESIS OF VITAMIN B12
Vitamin B12 (also known as cobalamin, Figure 2) refers to a
family of cobalt-containing, water soluble vitamins which are
required in several, unrelated metabolic pathways. Due to the
reactivity of its carbon-cobalt bond, B12-dependent enzymes are
able to catalyze isomerizations, methyltransfers, and dehalogena-
tions. Vitamin B12 presents an interesting focus for exploration
of the metabolic phylogeny of host-pathogen interactions. It is
likely that the progenitor eukaryotic cell included B12-dependent
enzymes but lacked the complex set of genes required for B12
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FIGURE 1 | Phylogeny ofM. tuberculosis and related actinomycetes. The
M. tuberculosis complex emerged by clonal expansion of a strain closely
related to the M. canettii cluster of slow-growing mycobacteria. The
actinomycete phylogenetic tree is based on 16S rRNA sequences. Briefly, the
corresponding sequences were aligned using the 16sRNA alignment tool
available in the RDP database (Cole et al., 2014). The resulting alignment was
analyzed with MEGA6 to infer a maximum likelihood phylogeny (Tamura et al.,
2013). The best-fit model of nucleotide evolution after Akaike information
criterion was Tamura-Nei with Gamma and invariants to model rate variation.
Thousand bootstrap pseudo-replicates were used to give statistical support to
the clades of the maximum likelihood topology. The M. tuberculosis complex
tree is based on whole genome SNP analysis as obtained in Comas et al.
(2013). Scale bar for the 16sRNA phylogeny reflects number of substitutions
per site. In the case of the whole genome MTBC phylogeny reflects number
of single nucleotide polymorphism. Numbers in the nodes of the 16sRNA
topology reflects the percentage of bootstrap replicates supporting each
node. No bootstrap support is shown for the MTBC phylogeny as all the case
were higher than 95% as shown in Comas et al. (2013).
biosynthesis. Only bacteria and archaea have the machinery
to synthesize vitamin B12 (Zhang et al., 2009; Doxey et al.,
2015). While animals continued to use B12-dependent enzymes
for methionine synthesis and methylmalonate metabolism, land
plants and fungi rely on B12-independent enzymes for these path-
ways. Divergent evolution of algae generated both B12-dependent
and B12-independent species (Helliwell et al., 2011). A fun-
damental feature inherent in the choice of a B12-dependent
lifestyle is that it involves commitment to symbiosis with B12-
producing bacteria, establishing a platform for the subsequent
evolution of pathogens. Many prokaryotes have also elected to
rely on community-acquired B12; bioinformatic analysis of whole
genome sequences identifies an intact B12 biosynthesis pathway
in only half of the bacteria that have B12-dependent enzymes
(Zhang et al., 2009). Supply and utilization of vitamin B12 by
bacteria can have an important impact on the metabolism of
eukaryotic partners in co-culture (Wang et al., 2014;Watson et al.,
2014). While it is unlikely that the relatively small numbers of
tuberculosis bacteria will influence overall B12 levels in infected
individuals, vitamin B12 produced or consumed bymycobacterial
pathogens may have a local effect on the metabolic environment
of human granulomatous lesions.
Mycobacteria and related actinomycetes generally retain the
ability to synthesize B12, predominantly by the aerobic path-
way, and Propionibacterium shermanii is used for production
of the vitamin (Martens et al., 2002). More distantly related
actinomycetes such as Arthrobacter and Bifidobacteria lack a
B12 pathway, though some Arthrobacter have a B12-dependent
methionine synthase. As highlighted by Boritsch et al. (2014) dis-
tinctive feature ofM. tuberculosis is that the cobF gene—encoding
a precorrin-6a synthase required for B12 synthesis—was deleted
during evolution from the M. canettii-like ancestor, along with
two further genes and N- and C-terminal portions of flank-
ing genes Rv0943c and Rv0944 (Supply et al., 2013). While this
may not entirely ablate B12 biosynthesis [it has been suggested
that alternative methyltransferases might partially compensate
for the loss of CobF (Rodionov et al., 2003; Gopinath et al.,
2013a)], it suggests that M. tuberculosis may have come to rely
on the host environment as a source of vitamin. Although clas-
sically, NrdZ and MutAB utilize adenosylcobalamin and MetH
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FIGURE 2 | Structure of vitamin B12 (cobalamin).
employs methylcobalamin, cofactor specificity for mycobacte-
rial enzymes has not been investigated. This is important in
all organisms that might synthesize one form of the cofactors
and uptake another. Importantly, species specific variation in
these cofactors, such as differences in the exact structure of the
lower ligand, could indicate that mycobacterial enzymes must
have greater ability to accommodate more than one form of
the cofactor. Similarly, while non-typhoidal Salmonellae retain
a B12 pathway, this is inactivated in human-adapted typhoidal
serovars (Gal-Mor et al., 2014; Nuccio and Baumler, 2014), and
Yersinia pestis and Yersinia pseudotuberculosis lack most of the
B12 biosynthesis genes present in Yersinia enterocolitica. The RD9
deletion causes further attrition of the B12 pathway, removing
the amino terminus of CobL, with likely polar effects on expres-
sion of CobM and CobK, and a predictive algorithm based on
primary sequence conservation (SIFT; Ng and Henikoff, 2003)
identifies three SNPs that are likely to impair cobalamin biosyn-
thesis enzymes in Lineage 5 isolates (CobM D53G, CobO Q202R,
CobU H50R). In the case of CobN/Rv2026c, screening a panel
of more than 200 clinical isolates representative of the global
diversity of M. tuberculosis (Comas et al., 2013) identifies 17
SNPs predicted to have an impact on protein function, two
strains with >1 kb deletion, and truncated proteins generated
by frameshift events. Historical experience suggests that the inci-
dence of active tuberculosis is markedly reduced in the context of
pernicious anemia (B12-deficiency) (Barron, 1933), and analysis
of recent data shows a slight increase in the risk of tuberculo-
sis during the first year after treatment for pernicious anemia
(Ramagopalan et al., 2013). These clinical findings are consistent
with a model in which cobalamin availability is a limiting factor
for the growth ofM. tuberculosis in vivo. Several studies have high-
lighted a complex effect of nutritional factors on susceptibility to
tuberculosis, including a potential links to low B12 availability in
vegetarian diets (Chanarin and Stephenson, 1988; Cegielski and
McMurray, 2004). The obligate pathogen M. leprae has a severely
reduced genome (Cole et al., 2001) lacking all of the B12 path-
way with the exception of a set of genes required for scavenging
exogenous B12 precursors (Rodionov et al., 2003; Zhang et al.,
2009; Gopinath et al., 2013a): cobT (ML0868), ML1149/Rv1314c
(ATP:cobalamin adenosyltransferase), and the BacA transporter
ML2084/Rv1819c (Gopinath et al., 2013b). The B12 pathway is
intact in M. marinum and M. kansasii.
These mutations suggest that M. leprae has fully adapted to
reliance on host-derived B12, that M. tuberculosis is at least par-
tially reliant on the host, and that M. marinum and M. kansasii
synthesize their own B12. We next screened for diversity in
the three pathways that utilize B12-dependent enzymes. In each
case the bacteria have the choice of favoring the B12-dependent
pathway or a parallel B12-independent mechanism.
BIOSYNTHESIS OF METHIONINE
B12-DEPENDENT METHIONINE SYNTHESIS
M. tuberculosis has a B12-dependent methionine synthase
(Rv2124c) with sequence characteristics matching the predomi-
nant form of MetH found in most actinomycetes (MetHa). MetH
catalyzes the B12-dependent synthesis of L-methionine (EC
2.1.1.13), utilizing L-homocysteine and 5-methyltetrahydrofolate
(N5-MeTHF) as substrates and generating tetrahydrofolate
(THF) as a co-product (Figure 3A). While MetHa shares key cat-
alytic residues and structural features with the common form of
MetH found in most bacteria and animals, sequence alignment—
30% identity with E. coli and 29% identity with human MetH—
shows it to have a distinct phylogenetic origin (Figure 4A).MetHa
is always located on the chromosome adjacent to a gene with
homology to ML1306 (Rv2125 in M. tuberculosis), one of 24
conserved “signature proteins” that define the Actinobacteria
phylum (Gao and Gupta, 2012). The function of the ML1306
proteins is unclear. Primary sequence analysis and structural
modeling suggest some similarity to chaperones involved in
assembly of the archaeal proteasome, but functional studies
in Streptomyces demonstrate a role in chromosome segregation
(Ditkowski et al., 2010), and structural analysis of the paralo-
gous protein Rv2714 (another actinobacteria signature protein)
revealed features reminiscent of purine nucleoside phosphory-
lases, carboxypeptidases, and bacterial peptidyl-tRNA hydrolases
(Grana et al., 2009).
Some actinomycetes have acquired an additional metH gene
resembling the common bacterial variant. Members of the genus
Salinispora are obligate marine actinomycetes associated with
sea sponges (Ziemert et al., 2014). While all of the sequenced
Salinispora genomes have an ML1306-linked MetHa, the major-
ity of S. pacifica isolates have an additional second MetH located
elsewhere on the genome (Figure 4B). Frankia are actinomycete
symbionts of plants (Tisa et al., 2013). While the obligate Frankia
symbiont of Datisca glomerata has a typical actinomycete MetHa,
other Frankia genomes have an alternative variant. Genome com-
parisons indicate that the original metHa gene was lost in most
Frankia species as part of a 2.5 kb deletion between the ML1306
homolog and a conserved gene encoding an enzyme belonging to
the haloalkanoic dehalogenase (HAD) superfamily, leaving only
the acquired MetH variant (Figure 4B).
Mycobacterium marinum (Stinear et al., 2008) resembles
Frankia sp. CcI3 in having an alternative MetH (MMAR_4825)
with only a residual fragment of the actinomycetemetHa sequence
found adjacent to ML1306 homolog (MMAR_3107) (Figure 4B).
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In most rapid-growing mycobacteria, as well as in members of the
Mycobacterium avium-intracellulare complex, the ML1306 site is
occupied by a non-actinomycete MetH (Figure 4B). Exceptions
include rapid-growing M. hassiacum and M. thermoresistibile
which have a MetHa similar to M. tuberculosis, M. canettii,
M. kansasii, M. xenopi, and M. leprae.
Comparison of genome sequences from clinical isolates reveals
extensive MetHa polymorphism within the M. tuberculosis com-
plex. Isolates from the sub-branch of EuroAmerican Lineage 4
that includes the well-characterized strain CDC1551 have a dele-
tion that generates a non-functional MetHa (Warner et al., 2007).
A further 20 non-synonymous SNPs spread throughout the pro-
tein are predicted to have an effect on enzyme function (Table 1).
FIGURE 3 | Biosynthesis of methionine. (A) Methionine synthase (MetH,
MetE) reaction. (B) Homocysteine S-methyltransferase (MmuM) reaction.
With the exception of E220D in Lineage 5, these SNPs occur close
to the tips of the phylogenetic tree affecting only one or a few
isolates and suggesting that they are of relatively recent origin.
The frequent occurrence of functional SNPs—in comparison to
MetE, for example—is consistent with the proposal of Warner
et al. (2007) that loss of MetHa might have some selective benefit.
B12-INDEPENDENT METHIONINE SYNTHESIS
M. tuberculosis has a putative B12-independent methionine syn-
thase (EC 2.1.1.14), Rv1133/MetE, similar to that found in a
wide range of bacteria. MetE catalyzes the B12-independent
synthesis of L-methionine from L-homocysteine (Figure 3A),
with N5-MeTHF as the methyl donor, similarly to MetH. A
B12-independent reaction (EC 2.1.1.10) can also be achieved
by transfer of a methyl group from S-adenosylmethionine by
homocysteine S-methyltransferase (Rv2458/MmuM), as shown
in Figure 3B. Rv2458 encodes anMmuM homolog inM. tubercu-
losis but does not substitute for MetE activity in a MetH knockout
background (Warner et al., 2007). This is likely a reflection of
the co-substrate needed in the reaction catalyzed by MmuM;
S-adenosylmethionine versus N5-MeTHF utilized by MetH and
MetE. As S-adenosylmethionine is synthesized by condensation
of methionine and ATP it is impossible for this pathway to sup-
ply enough methionine for physiologic demands, as it will always
consume one equivalent of S-adenosylmethione per methion-
ine made, which in turn needs methionine to be regenerated.
MmuM is conserved in the reduced genome of M. leprae but is
absent in rapid-growing mycobacteria and has been deleted from
M.marinum. In commonwith other actinomycetes,M. tuberculo-
sis has a predicted protein with sequence match to the C-terminal
catalytic domain of MetE (Rv3015c) that is often annotated as
a MetE homolog. However, the canonical MetE enzyme has a
FIGURE 4 | MetH switching in actinomycetes. (A) Phylogeny: The
MetHa protein of M. tuberculosis (TB) is similar to that commonly
found in actinomycetes including Streptomyces (STREP), Corynebacteria
(CORYNE), Propionibacteria (PROP), and Arthrobacter (ARTHRO). In
rapid-growing mycobacteria such as M. smegmatis (SMEG) MetH is
related to the conventional variant found in other bacteria and animals.
M. hassiacum (HASS) is an example of a rapid-growing mycobacterium
with the MetHa variant, while slow-growing M. marinum (MAR) has
MetH. One or both variants are found in Frankia (FRAN1/2) and
Salinispora (SAL1/2) isolates. The phylogenetic tree was generated using
the phylogeny.fr webserver (Dereeper et al., 2008). (B) Genome
location: MetHa is always located adjacent to the actinomycete
signature protein ML1306. Isolates of Salinispora pacifica include a
second MetH variant in a separate location. Acquisition of a MetH
variant in Frankia species is associated with deletion of MetHa. In
M. marinum and Frankia sp. CcI3, the ML1306 site contains a fragment
of MetHa; in both species an intact conventional MetH is present
adjacent to a prophage insertion into tRNA-Phe-GAA, suggesting its
possible introduction by horizontal transfer. Most rapid-growing
mycobacteria have a MetH variant at the ML1306 site.
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Table 1 |M. tuberculosis MetHa SNPs with predicted functional impact.
Position Ancestral Derived Mutation SIFT Isolates
2386028 G A L14F 0.03 L6_N0090, L6_414104
2385793 A C I92S 0.00 L2_M4100A
2385695 C T G125R 0.00 L4_155008, L4_GM1503, L4_N0146, L4_N0137, L4_X632
2385408 C A E220D 0.00 Lineage 5
2385338 G C H244D 0.00 L3_N0054
2385283 G A P262L 0.00 L4_V639EA
2385181 C T G296D 0.00 L1_T17
2385146 C T V308M 0.01 L6_N0060
2384545 A G I508T 0.03 L3_751B
2384452 C T R539H 0.02 L2_N0017, L2_981833
2384402 G T L556I 0.03 L6_538302
2384359 T C H570R 0.01 L7_BTBH935
2384009 T C T687A 0.04 L4_N0163
2383951 G T A706E 0.00 L1_N1004
2383903 C T R722H 0.00 L3_N1058
2383616 C T G818S 0.00 L3_162908, L3_155808, L3_159008
2383051 A C I1006S 0.00 L4_478304
2382954 G T F1038L 0.00 L1_N72, L1_N70, L1_N0182, L1_N0203
2382776 A C Y1098D 0.00 L2_N0010, L2_N0130, L2_N1037, L2_N0020, L2_N005, L2_N0150
2382623 G C R1149G 0.02 L6_N0090, L6_414104
2382501 G C Y1189X L4_N0148, L4_N1057
2383616 2382501 Deletion L4_CDC1551, L4_DY22, L4_N0142, L4_X581
Screening of a global diversity panel of M. tuberculosis isolates identified 25 non-synonymous SNPs in MetHa/Rv2124c; 21 of these are predicted by the SIFT
algorithm (Ng and Henikoff, 2003) to have an impact on enzyme function. A similar screen for MetE/Rv1133c identified 3 SNPs, only one of which is predicted to
affect function (L6_N0092). Strain numbers refer to Comas et al. (2013).
duplicated domain structure (Pejchal and Ludwig, 2005) and the
functional activity of the single domain proteins is unclear.
The catalytic turnover rate of E. coli MetH is 100-fold higher
than MetE (Gonzalez et al., 1992), conferring a clear metabolic
and ecological advantage in use of the B12-dependent path-
way when B12 is available. Equivalent kinetic and thermody-
namic constants for mycobacterial MetH, MetHa, and MetE are
unknown; their determination might provide a functional ratio-
nale forMetH switching events. Expression ofMetE in both E. coli
and M. tuberculosis is repressed in the presence of B12 by binding
of the cofactor to a regulatory riboswitch upstream of the metE
coding sequence (Vitreschak et al., 2003; Warner et al., 2007).
Warner et al. showed that in vitro culture of MetHa-negative
M. tuberculosis in the presence of exogenous B12 resulted in selec-
tion of mutations in the MetE riboswitch (Warner et al., 2007),
but there is no evidence of equivalent SNPs in clinical isolates with
MetHa deletions or mutations (Figure 5).
In contrast to MetE, accumulation of SNPs is observed in the
case of a second M. tuberculosis B12 riboswitch located upstream
of PPE2/Rv0256c (Vitreschak et al., 2003; Warner et al., 2007)
(Figure 5). The function of Rv0256c is unclear. The presence of
the riboswitch, together with a predicted membrane-spanning
structure and potential operon link to B12 biosynthesis genes, led
to a suggested role in cobalt transport (“CbtG”) (Rodionov et al.,
2003). A recent elegant genetic study identified the BacA trans-
porter as the sole determinant of cobalamin uptake by M. tuber-
culosis (Gopinath et al., 2013b). Riboswitch-regulated Rv0256c is
retained in other mycobacteria including M. leprae, though the
operon link to cob genes is variable.
During exponential growth of M. tuberculosis H37Rv, metE
and metHa transcripts are present at a similar abundance around
5-fold higher than themedian for all genes (Cortes et al., 2013). In
terms of protein abundance, however, MetE is in 100-fold excess
compared to MetHa (Cortes et al., 2013), suggesting that the
MetHa protein is either translated less efficiently, or is more read-
ily degraded. Proclivity to degradation might be a consequence
of poor stability of MetH in the absence of B12, and it can be
anticipated that addition of vitamin B12 to the growth medium
might alter the protein ratio. InM. marinum, themetH transcript
has an abundance matching the median level for all genes, with
metE transcript 10-fold lower (Wang et al., 2013). This is consis-
tent with the notion that contrary toM. tuberculosis,M. marinum
constitutively produces B12.
METHIONINE AND FOLATE METABOLISM
The methyl group for the MetH/MetE reaction is provided
by N5-MeTHF, and imbalance of vitamin B12 metabolism in
humans is often associated with imbalance in folate metabolism.
Similarly, disruption of methionine levels is observed in
para-aminosalicylic acid treated M. tuberculosis (Chakraborty
et al., 2013), indicating a tight coupling between folate
biosynthesis and methionine levels. N5-MeTHF is generated
from 5,10-methylenetetrahydrofolate by the MetF reductase, and
mycobacteria are unusual amongst the actinomycetes in lacking
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FIGURE 5 | SNP analysis of B12 riboswitches. M. tuberculosis has two
B12-dependent riboswitches, located upstream of Rv1133c (MetE) and
Rv0256c (PPE2). Riboswitch sequences identified by Vitreschak et al. (2003)
are underlined, −10 motifs and transcription start sites (Cortes et al., 2013)
are highlighted in yellow, and start codons in uppercase. Blue highlights show
SNPs identified in a panel of clinical isolates representative of the global
diversity of M. tuberculosis (see Comas et al., 2013, for details of isolates).
While there is evidence of diversification of the Rv0256c riboswitch, the
MetE riboswitch has been conserved during expansion of the M. tuberculosis
complex.
an annotated copy ofMetF. An exception isMycobacterium absces-
sus, in which a MetF homolog is present between genes encoding
lipoprotein LppM and geranylgeranyl pyrophosphate synthase
IdsA. Other mycobacteria have a conserved hypothetical in this
location; Rv2172c inM. tuberculosis. While Rv2172c shows no sig-
nificant primary sequence homology with MetF, fold-recognition
and structural modeling (Kelley and Sternberg, 2009) reveals a
significantmatch with the crystal structure ofMetF from Thermus
thermophilus, identifying Rv2172c as an atypical MetF homolog.
PROPIONYL-CoA CATABOLISM
METHYLMALONATE PATHWAY (B12-DEPENDENT)
Toxicity linked to the accumulation of propionyl-CoA deriva-
tives during catabolism of odd-chain fatty acids is countered
by their metabolism through either the B12-dependent methyl-
malonate pathway or the B12-independent methylcitrate cycle.
One or other of the two pathways is essential for growth of
M. tuberculosis on propionate (Munoz-Elias et al., 2006; Savvi
et al., 2008; Eoh and Rhee, 2014). Methylmalonyl-CoA is also an
important substrate for biosynthesis of cell wall lipids (Rainwater
and Kolattukudy, 1983, 1985; Azad et al., 1997; Fernandes and
Kolattukudy, 1998).
The methylmalonate pathway (Figure 6A) including B12-
dependent MutAB methylmalonyl-CoA mutase (EC 5.4.99.2) is
conserved across all mycobacteria includingM. leprae. Propionyl-
CoA enters the methylmalonate pathway through an essential
acyl-CoA carboxylase comprising alpha (AccA3), beta (AccD5),
and epsilon (AccE5) subunits (Gago et al., 2006; Lyonnet et al.,
2014). Rv3281, encoding the epsilon subunit, is highly polymor-
phic between mycobacterial species and across multipleM. tuber-
culosis isolates, with a predicted N-terminal domain consisting of
a variable number of repeat elements generating protein prod-
ucts that range from 85 to 203 amino acids. Functional activity of
the epsilon subunit is retained in a 76 amino acid fragment from
the conserved C-terminus [using valine-122 as start codon (Gago
et al., 2006)] and the role—if any—of the variable N-terminus
is unclear. Shotgun proteome analysis of M. tuberculosis H37Rv
detected five peptides spanning the sequence from valine-63 to
the C-terminus (Cortes et al., 2013) showing that at least part of
the variable N-terminus is translated into protein.
Mycobacterial Rv1492/MutA and Rv1493/MutB are presumed
to form an alpha-beta heterodimer structure analogous to the
well-characterized B12-dependent methylmalonyl-CoA mutase
from Propionibacterium shermanii (Cracan and Banerjee, 2012);
there is no evidence of diversification during the evolution of
M. tuberculosis. M. canettii, and hence M. tuberculosis, lacks
a locus containing a second mycobacterial methylmalonyl-CoA
mutase (McmA2, MMAR_4797/4798 in M. marinum). This is
Frontiers in Molecular Biosciences | Structural Biology March 2015 | Volume 2 | Article 6 | 6
Young et al. B12 metabolism in Mycobacterium tuberculosis
FIGURE 6 | Propionyl-CoA catabolism. (A) Methylmalonyl-CoA pathway in mycobacteria. (B) Methylcitrate cycle in mycobacteria.
a split-domain enzyme with substrate and B12 cofactor bind-
ing sites located on separate polypeptides. McmA2 is located in
a ∼150-gene region between Rv0838/LpqR and Rv0852/FadD16
that includes six conserved cytochrome P450 genes and an MCE
locus. M. tuberculosis has only 15 genes in this region, M. leprae
has eight genes and seven pseudogenes, and a 50-gene deletion
removes theMCE locus and three of the P450s inM. ulcerans. The
presence of a series of lipid-related enzymes in the MmcA2 region
suggests that the role of the mutase in this case may be to gen-
erate methylmalonyl-CoA units for biosynthesis of a secondary
metabolite or complex lipid that is missing from M. tuberculosis.
METHYLCITRATE CYCLE (B12-INDEPENDENT)
In the methylcitrate cycle (Figure 6B), 2-methylcitrate synthase
(PrpC) combines propionyl-CoA with oxaloacetate to form 2-
methylcitrate (EC 2.3.3.5), which is converted to methylisoci-
trate by PrpD dehydratase/hydratase (EC 4.2.1.79 and 4.2.1.99).
These two steps resemble the first two reactions in the Krebs
cycle, catalyzed by citrate synthase and aconitase, respectively.
Methylisocitrate lyase (MCL, PrpB) converts methylisocitrate
to pyruvate and succinate (EC 4.1.3.30) in a reaction analo-
gous to that catalyzed by isocitrate lyase (ICL) in the glyoxylate
shunt. In M. canettii/M. tuberculosis and in M. kansasii, a dele-
tion between PrpD/Rv1130 and PrpC/Rv1131 results in loss of
MCL. Differences in the length of residual intergenic sequence
in the two species—54 bp in M. tuberculosis and 130 bp in
M. kansasii—suggests that this may have occurred through two
independent events. The methylcitrate cycle remains fully func-
tional in M. tuberculosis, however, with ICL catalyzing the final
step (Munoz-Elias et al., 2006; Eoh and Rhee, 2014). MCL is also
disrupted by a frameshift mutation in M. ulcerans (Doig et al.,
2012).
Mycobacteria have two ICLs. Icl1 (Rv0467 in M. tubercu-
losis H37Rv) is a typical bacterial ICL, clustering with related
enzymes from other actinomycetes, Gram-positive and Gram-
negative bacteria (Figure 7). The second ICL—generally anno-
tated as AceA (Rv1915/Rv1916 in H37Rv)—is phylogenetically
distinct from other bacterial and fungal ICLs. A single nucleotide
deletion causes a frameshift in the aceA gene of H37Rv, resulting
in its expression as two separate polypeptides which are unable to
complete the methylcitrate cycle in an Icl1 mutant (Munoz-Elias
et al., 2006).
Evolution of MCL activity from an ICL template has been
studied in fungi and relevant amino acid changes have been
mapped (Muller et al., 2011). Comparison of the ICL sequence
from MCL-positive M. marinum with those from MCL-negative
M. tuberculosis andM. kansasii reveals no obvious adaptive muta-
tions, however, suggesting that the mycobacterial ICL has an
intrinsic ability to utilize either substrate (Gould et al., 2006).
The primary role of ICL is to catalyze conversion of isocitrate
to succinate and glyoxylate to maintain energy generation and
gluconeogenesis during growth on fatty acids. It can be antic-
ipated that assigning a dual role to ICL in the methylcitrate
cycle in addition to the glyoxylate shunt may require alter-
ations in regulatory networks. Activation of the glyoxylate shunt
in response to low glucose is controlled by the transcriptional
regulator RamB (Rv0465c) (Micklinghoff et al., 2009), while
expression of genes involved in the methylcitrate cycle is regu-
lated by PrpR (Rv1129c) (Masiewicz et al., 2012). Both regulators
bind to overlapping sites 80 bp upstream of the icl1 transcription
www.frontiersin.org March 2015 | Volume 2 | Article 6 | 7
Young et al. B12 metabolism in Mycobacterium tuberculosis
FIGURE 7 | Phylogenetic analysis of mycobacterial isocitrate lyase
(ICL) and 2-methylisocitrate lyase (MCL). Most mycobacteria have
ICL and MCL enzymes similar to those found in other bacteria. MCL
has been deleted from M. tuberculosis and M. kansasii and
M. leprae lacks both MCL and ICL1. Mycobacteria also have a second
isocitrate lyase (AceA) with a distinct phylogenetic origin. The ICL/MCL
phylogeny was obtained after homolog searching of the ICL and MCL
proteins present in M. tuberculosis and M. marinum. Muscle was
used for amino acid alignment and a maximum likelihood phylogeny
inferred as implemented in MEGA6 (Tamura et al., 2013). The JTT
model of amino acid substitution incorporating gamma and invariant
categories for rate variation was used. Thousand bootstrap
pseudoreplicates were analyzed to obtain statistical support for the
clades observed in the maximum likelihood topology.
start site. The binding site is conserved between MCL-positive
and MCL-negative mycobacteria, however, suggesting that while
there is an interplay between the two regulators, this predates
the loss of MCL. Sequence comparisons within the M. tubercu-
losis complex highlight an intriguing diversity in the amino acid
sequence of the RamB regulator. Four lineage-associated SNPs are
predicted to have an impact on RamB function: N36D in Lineage
6, R106C in Lineage 4, Q121R in Lineage 1, and K229T in Lineage
5. Impaired function of RamB would reduce repression of ICL in
the presence of glucose, potentially enhancing availability of ICL
for the methylcitrate cycle. Therefore, species-specific alterations
in regulatory networks further diversified by strain-specific SNPs
in transcriptional regulators allow expression of an originally
fatty acid catabolic pathway during growth on carbohydrates.
Changes such as these are believed to confer on M. tuberculosis
the unique ability to grow optimally with multiple types of car-
bon sources (de Carvalho et al., 2010; Rhee et al., 2011), which
is believed to be the case during infection. Further rewiring of
metabolic circuits linking glucose and fatty acid metabolism is
likely to accompany the inactivation of pyruvate kinase in Lineage
5, Lineage 6, and the associated animal-adapted strains (Keating
et al., 2005).
The origin and role of the second ICL in mycobacteria is
unclear.While themethylcitrate cycle genes have been deleted and
icl1 and ramB are reduced to pseudogenes in M. leprae, aceA and
malate synthase remain intact, providing the potential for a func-
tional glyoxylate shunt. Pyruvate kinase is intact in M. leprae, but
pyruvate carboxylase is a pseudogene.
BIOSYNTHESIS OF DEOXYRIBONUCLEOTIDES
Ribonucleotide reductases (RNRs) are essential enzymes in all liv-
ing cells, responsible for reduction of ribonucleotides to deoxyri-
bonucleotides (EC 1.17.4.1) (Figure 8); the building blocks
required for the synthesis of DNA.
B12-DEPENDENT RIBONUCLEOTIDE REDUCTASE
A B12-independent class Ib ribonucleotide reductase encoded by
Rv3051c/nrdE and Rv3048c/nrdF2 is both necessary and suffi-
cient to support growth of M. tuberculosis in a mouse model of
infection (Dawes et al., 2003; Mowa et al., 2009). In addition,
M. tuberculosis has a B12-dependent class II RNR, Rv0570 anno-
tated as NrdZ (generally referred to as NrdJ in other bacteria).
While the class I RNR requires oxygen, the class II enzyme has
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the potential to contribute an additional function under anaer-
obic conditions. In Pseudomonas aeruginosa, for example, a class
II RNR is required to support biofilm growth under anaerobic
conditions (Lee et al., 2012). It is important to note that B12
biosynthesis in mycobacteria requires oxygen, indicating that an
anaerobic B12-dependent RNR would have to obtain B12 from
exogenous sources under hypoxia.
Class II RNRs resemble class I and class III structurally
(Sintchak et al., 2002) and the enzyme from Lactobacillus leich-
mannii is a monomer, contrasting with the oligomeric class I
RNRs. In class II RNRs, the B12 cofactor is in its adenosylcobal-
amin form and is responsible for generation of the radical needed
for the deoxygenation of the ribonucleotide. Reducing equiv-
alents for the reaction are provided by oxidation of a pair of
cysteine residues in class II RNRs (Booker et al., 1994), similarly
to the mechanism described in class I RNRs.
NrdZ is differentially distributed amongst the mycobacteria
in a pattern that is inconsistent with conventional phylogeny
(Figure 9A); while it is present in slow-growing M. tuberculosis
FIGURE 8 | Ribonucleotide reductase reaction.
and M. kansasii and rapid-growing M. phlei, for example, it is
absent from M. marinum and M. smegmatis. The mycobacte-
rial class II RNR clusters separately from analogous enzymes
in other actinomycetes, with a stronger resemblance to archaeal
NrdJ (Figure 9B), suggesting its possible acquisition by horizon-
tal transfer. Consistent with this, NrdJ homologs are found in the
genomes of multiple mycobacteriophages (Dwivedi et al., 2013).
In a phylogenetic analysis mycobacteriophage NrdZs cluster sep-
arately from chromosomal NrdZs; copies of the phage variant are
integrated in the genomes of M. hassiacum (which also has an
NdrZ) and M. rhodesiae JS60.
Phylogenetic analysis reveals an extensive network of hori-
zontal exchange amongst the mycobacteria (Becq et al., 2007;
Stinear et al., 2008; Veyrier et al., 2009; Supply et al., 2013;
Boritsch et al., 2014; Wang and Behr, 2014). Features asso-
ciated with virulence attributes in M. tuberculosis—including
Type VII secretion and MCE loci—are commonly found in the
sequence of plasmids isolated from rapid-growing mycobacte-
ria, and genes present in multiple copies on the M. tuberculosis
genome—cytochrome P450s, adenylate cyclases, toxin-antitoxin
modules, and WhiB transcription factors—are present on plas-
mids, mycobacteriophages, and integrated conjugative elements
(Bordeleau et al., 2012). These may provide a pool of initially
unassigned functional units that can be customized for spe-
cific purpose in a particular niche, or else discarded. While
horizontal acquisition made an important contribution in evo-
lution of the common ancestor with M. canettii, there is little or
no evidence of horizontal transfer during diversification of the
M. tuberculosis complex. Most strikingly, in spite of strong selec-
tive pressure there is no evidence of exchange of drug-resistance
determinants. Presumably the pathogenic lifestyle of M. tubercu-
losis has resulted in its isolation from opportunities for horizontal
acquisition.
FIGURE 9 | Phylogeny of B12-dependent ribonucleotide reductase
(NrdZ). (A) Distribution of NrdZ in mycobacteria. NrdZ-positive mycobacteria
are boxed in blue. The distribution of NrdZ in mycobacteria does not align
with a conventional phylogeny. The mycobacteria phylogenetic tree is based
on 16S rRNA sequences as described for Figure 1. (B) Phylogenetic tree of
NrdZ/NrdJ. Mycobacterial NrdZ has a phylogenetic origin distinct from that of
class II RNRs in other eubacteria, clustering more closely with archaebacterial
NrdJ. Copies of NrdJ carried by mycobacteriophages and occasionally
inserted into mycobacterial genomes also have a separate phylogenetic
origin. The NrdZ phylogeny was obtained after homolog searching of the NrdZ
protein present in M. tuberculosis. Muscle was used for amino acid
alignment and a maximum likelihood phylogeny inferred as implemented in
MEGA6 (Tamura et al., 2013). The JTT model of amino acid substitution
incorporating gamma and invariant categories for rate variation was used.
Thousand bootstrap pseudoreplicates were analyzed to obtain statistical
support for the clades observed in the maximum likelihood topology.
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NrdZ is part of the DosR regulon in M. tuberculosis, which
comprises a set of genes that are induced in response to stress
stimuli sensed by a two-component regulator (Park et al., 2003).
Characterization of the DosR regulon in mycobacteria and
related actinomycetes has identified a set of common “core”
genes encoding universal stress proteins, α-crystallin chaperones,
nitroreductase-domain proteins, triacylglyceride synthases, and
YfiA-like hibernation factors that are presumed to facilitate tran-
sition to a survival phenotype, together with a set of “peripheral”
genes with restricted distribution (Gerasimova et al., 2011). The
DosR regulon in M. tuberculosis is triggered by exposure to nitric
oxide, carbon monoxide, or hypoxia. NrdZ is a peripheral com-
ponent of the DosR regulon and may have specific relevance
for hypoxic survival of M. tuberculosis. In M. tuberculosis, NrdZ
is located in a 63-gene region between Rv0568/Cyp136B and
Rv0629/RecD, that includes seven toxin-antitoxin modules and
an mce locus. This region has only 17 genes in M. marinum,
while the corresponding 61-gene region in M. kansasii includes
NrdZ (MKAN_19005) and other genes linked to anaerobic
metabolism. These anaerobic functions are missing fromM. mar-
inum and M. leprae and may have been acquired by horizontal
transfer.
The NrdZ locus in M. tuberculosis and M. kansasii also
includes the peripheral DosR regulon gene pncB2 (Rv0573c,
MKAN_19060) encoding a phosphoribosyltransferase involved in
nicotinamide salvage. Again, PncB2 is absent from M. marinum.
Nicotinamide provides another example of a vitamin that can be
shared by host and pathogen.WhileM. tuberculosis has the poten-
tial to synthesize nicotinamide adenine dinucleotide (NAD+)
de novo, growth of an nadABC deletion mutant in a mouse
model (Vilcheze et al., 2010) shows that—in common with other
human pathogens including Shigella flexneri, Streptococci and
Staphylococcus aureus (Prunier et al., 2007; Sorci et al., 2013)—
M. tuberculosis is able to scavenge nicotinamide from the host
during infection. However, while M. leprae has preserved the
capacity for de novo synthesis, it has lost the pncA and pncB sal-
vage pathway genes. PncA is inactivated by an H57D SNP in
cattle-adapted M. bovis, an L177R SNP is predicted to impact
PncB2 function in Lineage 5, and PncA mutations are selected in
pyrazinamide-resistant strains of M. tuberculosis without incur-
ring any loss in pathogenesis, suggesting that retention of de novo
synthesis is preferred over host scavenging as a source of the vita-
min. Retention of different pathways by different pathogens may
reflect selective pressures linked to nicotinamide availability in
particular colonization niches.
B12-INDEPENDENT RIBONUCLEOTIDE REDUCTASE
Genes encoding components of the major class Ib RNR—NrdE
(Rv3051c) and NrdF2 (Rv3048c), with electrons supplied by
NrdH (Rv3053c) and NrdI (Rv3052c)—are conserved in all
mycobacteria, and additional genes with sequence homology to
the thioredoxin/glutaredoxin-like NrdH are found on plasmids
and mycobacteriophages (Dwivedi et al., 2013). In addition, in
common with some other mycobacteria,M. tuberculosis has a sec-
ond beta subunit gene (NrdF1/Rv1981c) and a gene encoding a
third beta subunit that resembles a class Ic RNR (NrdB/Rv0233).
While the alternative beta subunits are not essential for normal
growth (Mowa et al., 2009), NrdF1 is active in a biochemical assay
(Hammerstad et al., 2014) and it is possible that they make some
contribution to survival in particular environments. The differen-
tial distribution of NrdB amongst mycobacterial species and the
presence of a homolog on a plasmid from M. yongonense (pMy-
ong1, OEM_p100240) suggest that it is also subject to exchange
by horizontal transfer.
Expression of the class Ib RNR is regulated by transcription
factor NrdR binding to characteristic tandem sites upstream of
nrdF2 and nrdH (Rodionov and Gelfand, 2005). Consistent with
the demonstration of repressor function for NrdR (Mowa et al.,
2009), the binding sites are located at positions +15.5/+47.5
(nrdF2) and +15.5/+60.5 (nrdH) with respect to transcription
start sites at 3409418 and 3415168, respectively (Cortes et al.,
2013). The 32 bp spacing between tandemNrdR sites upstream of
nrdH (Rodionov andGelfand, 2005) is extended inM. tuberculosis
H37Rv by duplication of a 13 bp sequence. In isolates belonging
to “modern” Eurasian Lineages 2, 3, and 4 and Ethiopian Lineage
7, a C/T SNP at position 3415332 generates a new TANNNT −10
consensus motif (Rose et al., 2013) and an additional transcrip-
tion start site upstream of NrdH providing the potential for
NrdR-independent expression.
UTILIZATION OF ETHANOLAMINE
The ability to utilize ethanolamine is an important viru-
lence determinant for enteric pathogens (Garsin, 2010) and
M. marinum has eutB and eutC genes encoding a predicted
B12-dependent ethanolamine ammonia-lyase. These genes are
inserted along with an ethanolamine transporter and an adeny-
late cyclase between the end of a carbon monoxide dehy-
drogenase locus (MMAR_0662/Rv0368c) (Cook et al., 2014)
and a conserved glycosyl hydrolase (MMAR_0667/Rv0365c). In
M. tuberculosis this location is occupied by genes encoding a
zeta-epsilon toxin-antitoxin pair (Rv0367c-Rv0366c). Amongst
the slow-growing mycobacteria, the three ethanolamine utiliza-
tion genes are also present in M. gastri, and M. parascrofu-
laceum has copies of eutB and eutC. In host-adapted M. ulcerans,
eutB, the ethanolamine transporter and the adenylate cyclase are
present in the form of pseudogenes. A subset of rapid-growing
mycobacteria, including M. smegmatis mc2155, have the poten-
tial for ethanolamine utilization, with the relevant enzymes likely
sequestered within specialized microcompartments (Axen et al.,
2014).
CONCLUDING COMMENTS
An important barrier to understanding the biology of infection—
and design of effective antibacterial agents—is that the physiology
of bacteria growing in culture differs from that of the same bacte-
ria in the host. Direct characterization of the in vivo metabolome
faces the technical limitation that the vast majority of metabo-
lites are common to both host and pathogen and, at least in the
case of tuberculosis, that the heterogeneity of lesions is likely to be
mirrored by a corresponding heterogeneity in relevant metabolic
phenotypes (Barry et al., 2009). Evolutionary biology offers an
alternative approach of using phylogenetic evidence of adaptation
to identify areas of metabolism that may play a crucial role in
successful pathogenesis. We have used vitamin B12-dependent
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FIGURE 10 | Differences and similarities between B12-related metabolism between M. tuberculosis,M. leprae and M. marinum.
metabolism in M. tuberculosis to explore this strategy, allow-
ing us to sample adaptations to metabolic pathways involved
in methionine synthesis, methylmalonate processing, and DNA
metabolism. Figure 10 summarizes differences in B12-related
metabolism between M. tuberculosis and related mycobacterial
pathogens M. marinum and M. leprae.
Phylogenetic analysis highlights a marked difference in
the evolution of anaerobic metabolism between closely-related
pathogens. While M. marinum lacks a class II ribonucleotide
reductase and constitutive as well as DosR-regulated enzymes for
nitrate respiration, these genes are all present in M. tuberculosis
together with a fumarate reductase that contributes to reduc-
tive operation of the TCA cycle (Rv1552-Rv1555, likely to have
been acquired by horizontal transfer) (Watanabe et al., 2011).
Further mutations that enhance constitutive expression of the
NarG operon and the DosR regulon have been acquired by mod-
ern lineages of M. tuberculosis (Rose et al., 2013) suggesting an
increasing reliance on anaerobic metabolism. This is consistent
with inferences from experimental models (Via et al., 2008), but
the phylogenetic evidence provides an additional important link
to the role of hypoxia in the long-term context of host-pathogen
co-evolution in human populations. While M. marinum has
attractive properties as a surrogate model for tuberculosis drug
discovery (Takaki et al., 2012), it would not be an appropriate
choice in the case of drugs targeting hypoxic phenotypes. Similar
toM. marinum, theM. leprae genome shows no evidence of a role
for anaerobic metabolism.
Phylogenetic analysis highlights a dynamic exchange of genes
amongst mycobacteria by horizontal transfer mediated by phages,
plasmids, and conjugative elements that is likely to have played a
crucial role in pre-adaptation of M. tuberculosis to its pathogenic
role. While several M. tuberculosis virulence determinants can be
traced back to horizontal acquisition by theM. canettii-like ances-
tor (Veyrier et al., 2009; Supply et al., 2013; Wang and Behr,
2014), it cannot be assumed that all such acquisitions reflect
positive selection—many unique loci may simply be “passing
through,” unlinked to functional biology of the host organism.
The absence of further gene acquisition during diversification of
the M. tuberculosis complex is a fundamentally important aspect
of the biology of tuberculosis. M. tuberculosis is forced to rely on
alterations to its existing genetic complement to optimize sur-
vival in an evolving human host, and is denied access to mobile
drug-resistance elements. It has been proposed that M. tubercu-
losis has adapted to a more virulent phenotype over the course
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of its co-evolution with human populations (Comas et al., 2013);
changes in vitamin B12 availability during the Neolithic transi-
tion from predominantlymeat-eating hunter gatherers to vegetar-
ian farmers represents one potential stimulus for mycobacterial
adaptation.
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